Company Encyclopedia
View More
name
Wisdomtree International Multifactor Fund
DWMF.US
News
View More

Teva (NYSE:TEVA) Valuation Check After Strong Q3, Margin Targets and Deleveraging Drive a Sharp Share Price Rebound

Teva Pharmaceutical Industries (NYSE:TEVA) has seen a sharp share price rebound after strong Q3 results, with revenue up 3% and improved debt ratios. The stock returned 36% in one month and 46.9% in three months, reaching $27.83. Analysts suggest Teva is 20% undervalued, with potential growth from biosimilars and innovative drugs. However, its high PE ratio of 44.8x raises caution compared to industry averages. Investors are advised to consider risks and opportunities in Teva's turnaround story.

Simplywall·
US
TEVA
+2.08%
Simplywall·
US
TEVA
+2.08%

AT&T sues generic drugmakers over alleged price-fixing scheme

AT&T and its employee benefit trust have sued dozens of generic drug manufacturers in U.S. federal court, accusing them of orchestrating a conspiracy to inflate prices on hundreds of medications since at least 2009. The lawsuit alleges antitrust violations and seeks unspecified monetary damages. Companies involved include Teva Pharmaceuticals, Sun Pharma, Sandoz, Glenmark, and Amneal. This adds to ongoing private and state enforcement actions targeting generic drug pricing.

Reuters·
US
T
+0.28%
US
TEVA
+2.08%
Reuters·
US
T
+0.28%
US
TEVA
+2.08%

Nestle India receives tax penalty of 82.8 million rupees

Nestle India receives tax penalty of 82.8 million rupees

marketscreener·
US
NSRGY
+0.65%
US
NSRGF
+0.91%
marketscreener·
US
NSRGY
+0.65%
US
NSRGF
+0.91%

Teva Pharmaceutical Industries Insider Sold Shares Worth $1,301,505, According to a Recent SEC Filing

Teva Pharmaceutical Industries Insider Sold Shares Worth $1,301,505, According to a Recent SEC Filing

marketscreener·
US
TEVA
+2.08%
marketscreener·
US
TEVA
+2.08%

Teva Director Roberto Mignone Reports Disposal of Common Shares

Roberto Mignone, a Director at Teva Pharmaceutical Industries Ltd., reported the disposal of common shares in the company. This information was published via the EDGAR system by the U.S. Securities and Exchange Commission on December 1, 2025. The news is generated by Public Technologies using AI and is for informational purposes only.

Reuters·
US
TEVA
+2.08%
Reuters·
US
TEVA
+2.08%
© 2025 Longbridge｜Disclaimer